News
February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more than 20 countries in Europe, Asia, New Zealand and Africa.
February 18, 2008
News
February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car
February 18, 2008News
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.
February 18, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
February 18, 2008 - Treating patients who have occlusive femoropopliteal disease with paclitaxel-coated balloons during ...
February 17, 2008News
February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies, Niaspan (Abbott’s proprietary niacin extended-release) and simvastatin, offering patients a new option for reaching healthy lipid levels.
February 17, 2008
Technology
Siemens Healthcare will highlight the Magnetom Essenza which features 30 mT/m gradients, reportedly delivering excellent ...
February 17, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart Journal (2008; Vol. 155, Issue 1: 128-132).
February 17, 2008News
February 15, 2008 - Siemens received FDA 510(k) clearance for Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.
February 14, 2008News
February 15, 2008 - The Sorin Group is launching the Sorin MEMO 3D Annuloplasty Ring for mitral valve repair clinical ...
February 14, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
Siemens offers the Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.
February 14, 2008
Feature | Dave Fornell
February 2008 - Ken Willis, RT (R)(CV), is the radiology informatics PACS engineer for Baptist Health in Montgomery, AL. His healthcare system recently completed its first installation of LCDs in 27 operating rooms spread over three hospitals. The installation included 60 NDS Surgical Imaging DS 42-inch LCDs.
February 13, 2008News
February 14, 2008 - A new approach called Hybrid Maze combines techniques from two existing procedures to offer patients a minimally invasive treatment for atrial fibrillation.
February 13, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
February 14, 2008 - At age 20, Vanessa Cirillo suffered a heart attack caused by a virus. She recovered and lived a ...
February 13, 2008News
February 13, 2008 - Orqis Medical Corp’s MOMENTUM Trial Abstract was accepted for a late breaking clinical trial ...
February 12, 2008Feature
February 13, 2008 – MEDRAD Inc. delivered the 10,000th Mark V ProVis Angiography Injection System, which is used worldwide for live imaging during therapeutic interventions and diagnostic angiography procedures, demonstrating consistent demand for the system in cardiology, interventional radiology and vascular surgery despite a trend toward noninvasive CT and MR for diagnostic procedures.
February 12, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now